Satish Jindal

General Partner

Satish joined Advent in January 2022 after serving as a CEO of BioMotiv, an operating investment fund.

Satish did his postdoctoral research at Whitehead Institute at MIT. Satish was a co-founder and CEO of NeoGenesis (acquired by Schering-Plough, now Merck), Co-founder and President of Verastem (NADAQ: VSTM) and co-founder of Elicio Therapeutics.

He also served as Vice President and Site Head at Schering-Plough in Cambridge, Massachusetts (now Merck), and Vice President and Site Head at Bristol-Myers Squibb.

He obtained a PhD in Biochemistry from Punjab University in India.

Assistant  Bonita Theara
T. +44 (0)20 7932 2157